Electronically facilitated transdermal delivery of human parathyroid hormone (1-34)

被引:36
|
作者
Medi, BA [1 ]
Singh, J [1 ]
机构
[1] N Dakota State Univ, Coll Pharm, Dept Pharmaceut Sci, Fargo, ND 58102 USA
关键词
transdermal drug delivery; electroporation; iontophoresis; hPTH (1-34); porcine skin;
D O I
10.1016/S0378-5173(03)00337-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Electronically facilitated transdermal delivery of human parathyroid hormone (1-34), hPTH (1-34), was investigated in vitro, using dermatomed porcine skin. The effect of iontophoretic current density,electroporative pulse voltages and also electroporation followed by iontophoresis was investigated on the in vitro percutaneous absorption of hPTH (1-34). Iontophoresis at 0.5 mA/cm(2) Current density significantly enhanced (P < 0.05) the flux of hPTH (1-34) in comparison to passive flux. Electroporation pulses of 100, 200 and 300 V significantly increased (P < 0.05) the flux of hPTH (1-34) in comparison with the passive as well as iontophoretic flux at 0.5 mA/cm(2). The electroporative flux of hPTH (1-34) was found to vary linearly (R-2 = 0.97) with the pulse amplitude. The principal barrier of the skin, stratum corneum, was found perturbed following the pulses as evident by light microscopy studies. The application of electroporation pulses followed by iontophoresis further increased the flux by several fold. The flux of hPTH (1-34) with the electroporation Pulses Of 100 and 300V followed by iontophoresis at 0.2 mA/cm(2) was 10- and 5-fold higher, respectively, in comparison to the flux with corresponding pulses alone. This shows the synergistic effect of iontophoresis in combination with electroporation on skin permeability of hPTH (1-34). The results indicate the possibility of designing controlled transdermal delivery systems for hPTH (1-34) using electroporation followed by iontophoresis. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 50 条
  • [21] In vivo studies of the inhibitory effects of parathyroid hormone(1-34) and parathyroid hormone-related protein(1-34) on ruminal motility
    Harmeyer, J
    Care, AD
    COMPARATIVE ENDOCRINOLOGY OF CALCIUM REGULATION, 1996, : 171 - 175
  • [22] Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats
    Codrons, V
    Vanderbist, F
    Verbeeck, RK
    Arras, M
    Lison, D
    Préat, V
    Vanbever, R
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) : 938 - 950
  • [23] High-level production of recombinant human parathyroid hormone 1-34
    Suzuki, Y
    Yabuta, M
    Ohsuye, K
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1998, 64 (02) : 526 - 529
  • [24] BIOLOGIC ACTIVITIES OF PARATHYROID-HORMONE (1-34) AND PARATHYROID-HORMONE - RELATED PEPTIDE (1-34) IN ISOLATED PERFUSED RAT FEMUR
    LOPEZHILKER, S
    MARTIN, KJ
    SUGIMOTO, T
    SLATOPOLSKY, E
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1992, 119 (06): : 738 - 743
  • [25] Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice
    Alexander, JM
    Bab, I
    Fish, S
    Müller, R
    Uchiyama, T
    Gronowicz, G
    Nahounou, M
    Zhao, Q
    White, DW
    Chorev, M
    Gazit, D
    Rosenblatt, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (09) : 1665 - 1673
  • [26] IMMUNOLOGICAL COMPARISON OF 2 SYNTHETIC HUMAN PARATHYROID HORMONE(1-34) PEPTIDES
    SEGRE, GV
    POTTS, JT
    CLINICAL RESEARCH, 1975, 23 (05): : A594 - A594
  • [27] IMMUNOLOGICAL PROPERTIES OF A SYNTHETIC 1-34 FRAGMENT OF HUMAN PARATHYROID-HORMONE
    HENDY, GN
    BARLING, PM
    ORIORDAN, JL
    JOURNAL OF ENDOCRINOLOGY, 1974, 63 (02) : P26 - P27
  • [28] Parathyroid hormone (1-34) has no direct effect on human atrial tissue
    Kolesnik, E.
    Verheyen, N.
    Krainer, T.
    Wallner, M.
    Maechler, H.
    Tomischitz, A.
    Pilz, S.
    Brussee, H.
    von Lewinski, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S314 - S314
  • [30] SYNTHETIC HUMAN PARATHYROID-HORMONE 1-34 FRAGMENT FOR DIAGNOSTIC TESTING
    MALLETTE, LE
    ANNALS OF INTERNAL MEDICINE, 1988, 109 (10) : 800 - 804